302 related articles for article (PubMed ID: 34000362)
1. Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabis.
Aviram J; Lewitus GM; Pud D; Procaccia S; Berman P; Yellin B; Vysotski Y; Hazan O; Eisenberg E; Meiri D
Pharmacol Res; 2021 Jul; 169():105651. PubMed ID: 34000362
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in medical cannabis-related adverse effects.
Aviram J; Lewitus GM; Vysotski Y; Berman P; Shapira A; Procaccia S; Meiri D
Pain; 2022 May; 163(5):975-983. PubMed ID: 34538843
[TBL] [Abstract][Full Text] [Related]
3. A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis.
Berman P; Futoran K; Lewitus GM; Mukha D; Benami M; Shlomi T; Meiri D
Sci Rep; 2018 Sep; 8(1):14280. PubMed ID: 30250104
[TBL] [Abstract][Full Text] [Related]
4. Phytocannabinoids for the Treatment of Neuropathic Pain: A Scoping Review of Randomised Controlled Trials Published Between 2012 and 2023.
Lewis M; Baroutian S; Hanning SM
Curr Pain Headache Rep; 2024 Mar; 28(3):109-118. PubMed ID: 38095748
[TBL] [Abstract][Full Text] [Related]
5. Medical Cannabis Use and Inflammatory Cytokines and Chemokines Among Adult Chronic Pain Patients.
Ajrawat P; Yang Y; Wasilewski E; Leroux T; Ladha KS; Bhatia A; Singh M; Thaker S; Kapoor M; Furlan AD; Kotra LP; Clarke H
Cannabis Cannabinoid Res; 2024 Feb; 9(1):267-281. PubMed ID: 36342776
[No Abstract] [Full Text] [Related]
6. Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort.
Baron EP; Lucas P; Eades J; Hogue O
J Headache Pain; 2018 May; 19(1):37. PubMed ID: 29797104
[TBL] [Abstract][Full Text] [Related]
7. Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence.
Jensen B; Chen J; Furnish T; Wallace M
Curr Pain Headache Rep; 2015 Oct; 19(10):50. PubMed ID: 26325482
[TBL] [Abstract][Full Text] [Related]
8. The Role of Cannabis, Cannabidiol and Other Cannabinoids in Chronic Pain. The Perspective of Physicians.
Köstenberger M; Nahler G; Jones TM; Neuwersch S; Likar R
J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):318-333. PubMed ID: 34467511
[TBL] [Abstract][Full Text] [Related]
9. Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol.
Linciano P; Citti C; Russo F; Tolomeo F; Laganà A; Capriotti AL; Luongo L; Iannotta M; Belardo C; Maione S; Forni F; Vandelli MA; Gigli G; Cannazza G
Sci Rep; 2020 Dec; 10(1):22019. PubMed ID: 33328530
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and correlates of medical cannabis patients' use of cannabis for recreational purposes.
Morean ME; Lederman IR
Addict Behav; 2019 Jun; 93():233-239. PubMed ID: 30772776
[TBL] [Abstract][Full Text] [Related]
11. No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms.
Gruber SA; Smith RT; Dahlgren MK; Lambros AM; Sagar KA
Exp Clin Psychopharmacol; 2021 Apr; 29(2):147-156. PubMed ID: 33764103
[TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study.
Eisenberg E; Ogintz M; Almog S
J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):216-25. PubMed ID: 25118789
[TBL] [Abstract][Full Text] [Related]
13. Cannabis and Cannabinoids for Chronic Pain.
Romero-Sandoval EA; Kolano AL; Alvarado-Vázquez PA
Curr Rheumatol Rep; 2017 Oct; 19(11):67. PubMed ID: 28983880
[TBL] [Abstract][Full Text] [Related]
14. Enantioseparation of chiral phytocannabinoids in medicinal cannabis.
Russo F; Tolomeo F; Angela Vandelli M; Biagini G; Laganà A; Laura Capriotti A; Cerrato A; Carbone L; Perrone E; Cavazzini A; Maiorano V; Gigli G; Cannazza G; Citti C
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Apr; 1221():123682. PubMed ID: 36965450
[TBL] [Abstract][Full Text] [Related]
15. Cannabis-based medicines and pain: a review of potential synergistic and entourage effects.
Anand U; Pacchetti B; Anand P; Sodergren MH
Pain Manag; 2021 Apr; 11(4):395-403. PubMed ID: 33703917
[TBL] [Abstract][Full Text] [Related]
16. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
Lal S; Shekher A; Puneet ; Narula AS; Abrahamse H; Gupta SC
Pharmacol Res; 2021 Jan; 163():105302. PubMed ID: 33246167
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Whiting PF; Wolff RF; Deshpande S; Di Nisio M; Duffy S; Hernandez AV; Keurentjes JC; Lang S; Misso K; Ryder S; Schmidlkofer S; Westwood M; Kleijnen J
JAMA; 2015 Jun 23-30; 313(24):2456-73. PubMed ID: 26103030
[TBL] [Abstract][Full Text] [Related]
18. Constituents of Cannabis Sativa.
Rock EM; Parker LA
Adv Exp Med Biol; 2021; 1264():1-13. PubMed ID: 33332000
[TBL] [Abstract][Full Text] [Related]
19. Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies.
Cooper ZD; Abrams DI
Am J Drug Alcohol Abuse; 2019; 45(6):580-595. PubMed ID: 31687845
[No Abstract] [Full Text] [Related]
20. Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil.
Morini L; Porro G; Liso M; Groppi A
Curr Pharm Biotechnol; 2017; 18(10):828-833. PubMed ID: 29189144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
